A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).

MLA

DeWire, Mariko, et al. “A Phase I/II Study of Ribociclib Following Radiation Therapy in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG).” Journal of Neuro-Oncology, vol. 149, no. 3, Sept. 2020, pp. 511–22. EBSCOhost, https://doi.org/10.1007/s11060-020-03641-2.

APA

DeWire, M., Fuller, C., Hummel, T. R., Chow, L. M. L., Salloum, R., de Blank, P., Pater, L., Lawson, S., Zhu, X., Dexheimer, P., Carle, A. C., Kumar, S. S., Drissi, R., Stevenson, C. B., Lane, A., Breneman, J., Witte, D., Jones, B. V., Leach, J. L., & Fouladi, M. (2020). A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG). Journal of Neuro-Oncology, 149(3), 511–522. https://doi.org/10.1007/s11060-020-03641-2

Chicago

DeWire, Mariko, Christine Fuller, Trent R. Hummel, Lionel M. L. Chow, Ralph Salloum, Peter de Blank, Luke Pater, et al. 2020. “A Phase I/II Study of Ribociclib Following Radiation Therapy in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG).” Journal of Neuro-Oncology 149 (3): 511–22. doi:10.1007/s11060-020-03641-2.